Published: 17 November 2015
HPV Immunisation Uptake Statistics
Published: 25 September 2015
Childhood Immunisation Statistics
Children in Scotland are protected through immunisation against many serious infectious diseases. Vaccination programmes aim both to protect the individual and to prevent the spread of these illnesses within the population. As a public health measure, immunisations have been hugely effective in reducing the burden of disease. It is of public health concern when immunisation rates fall, as this increases the possibility of disease transmission, and hence complications arising from outbreaks of infectious diseases.
The UK Childhood Immunisation Schedule covers the recommended immunisations for children and young people (aged 0 to 18 years). The schedule comprises the recommended universal or routine immunisations which are offered to all children and young people, as well as selective immunisations which are targeted to children at higher risk from certain diseases. Further information about the current immunisation programmes in Scotland, the vaccines available, and the diseases they protect against, can be found via the NHS Health Scotland Immunisation website www.immunisationscotland.org.uk
In Scotland the target of the national immunisation programme is for 95% of children to complete courses of the following routine childhood immunisations by 24 months of age: Diphtheria, Tetanus, Pertussis, Polio, Hib, Men C and Pneumococcal Conjugate Vaccine (PCV). An additional target of 95% uptake of one dose of Measles, Mumps and Rubella (MMR) vaccine by 5 years old (with a supplementary measure at 24 months) was introduced in 2006 to focus efforts to reduce the number of susceptible children entering primary school.
The following information on immunisation uptake rates for children and young people is available:
This provides information on uptake of routine immunisations for children in Scotland up to six years of age, excluding flu vaccine which is published by Health Protection Scotland (HPS) in HPS National Influenza Reports. An annual report, covering calendar year uptake rates, is published in March each year. In addition tables presenting uptake rates are published quarterly.
The Human Papillomavirus (HPV) vaccine is designed to protect against the two types of HPV that cause around 75% of cases of cervical cancer. The HPV vaccine does not protect against all cervical cancers, so regular cervical screening is still important. The immunisation programme aims to help protect girls against developing cervical cancer later in life by routinely immunising them in early secondary school, at around 11 to 13 years of age.
Uptake rates of teenage booster immunisations, which are offered at around 14 years of age.